Edition:
United States

United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

113.08USD
11:01am EDT
Change (% chg)

$0.09 (+0.08%)
Prev Close
$112.99
Open
$113.13
Day's High
$114.69
Day's Low
$112.89
Volume
21,683
Avg. Vol
188,310
52-wk High
$152.55
52-wk Low
$106.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 464.70 2.045
Sep '17 445.50 6.265
Jun '17 444.60 -1.247
Mar '17 370.50 3.891
FY 2016 Dec '16 409.00 2.435
Sep '16 408.20 3.502
Jun '16 412.60 4.394
Mar '16 369.00 4.836
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 8 388.73 457.80 345.90 --
Quarter Ending Sep-18 8 331.78 363.20 272.24 --
Year Ending Dec-18 12 1,428.34 1,568.60 1,346.80 1,349.45
Year Ending Dec-19 11 1,218.89 1,374.27 901.48 1,207.62
Earnings (per share)
Quarter Ending Jun-18 8 3.40 4.81 2.80 --
Quarter Ending Sep-18 8 2.77 3.36 1.69 --
Year Ending Dec-18 10 11.88 14.68 10.10 11.08
Year Ending Dec-19 9 10.02 12.39 5.74 8.78
LT Growth Rate (%) 1 -16.70 -16.70 -16.70 -26.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 10.31 185.16 33.25
P/E High - Last 5 Yrs. 34.48 283.72 45.98
P/E Low - Last 5 Yrs. 9.41 95.28 24.86
Beta 1.32 0.75 0.80
Price to Sales (TTM) 2.81 137.70 7.20
Price to Book (MRQ) 2.30 19.28 5.06
Price to Tangible Book (MRQ) 2.34 24.18 6.69
Price to Cash Flow (TTM) 9.33 120.88 25.20
% Owned Institutions -- 11.42 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.76
Dividend 5 Year Growth Rate -- 1.94 3.96
Payout Ratio(TTM) 0.00 9.17 20.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 13.62 81.55 8.73
Sales (TTM) vs TTM 1 Yr. Ago 7.91 97.79 11.30
Sales - 5 Yr. Growth Rate 13.50 33.72 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.99 -66.22 22.52
EPS (TTM) vs TTM 1 Yr. Ago -27.77 -- --
EPS - 5 Yr. Growth Rate 13.76 47.04 10.26
Capital Spending - 5 Yr. Growth Rate -5.06 45.24 10.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.01 1.64 2.53
Current Ratio (MRQ) 3.26 6.01 3.61
LT Debt to Equity (MRQ) 11.79 23.49 11.52
Total Debt to Equity (MRQ) 11.79 25.92 14.21
Interest Coverage (TTM) 272.23 -189.88 30.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 93.87 34.63 54.09
Gross Margin - 5 Yr. Avg. 92.99 55.35 52.20
EBITD Margin (TTM) 61.20 -- --
EBITD - 5 Yr. Avg 52.48 -153.57 15.86
Operating Margin (TTM) 44.36 -573.06 3.97
Operating Margin - 5 Yr. Avg. 46.66 -165.53 11.17
Pre-Tax Margin (TTM) 44.60 -545.71 4.62
Pre-Tax Margin - 5 Yr. Avg. 51.12 -172.26 11.49
Net Profit Margin (TTM) 28.34 -534.59 1.24
Net Profit Margin - 5 Yr. Avg. 32.92 -172.04 7.83
Effective Tax Rate (TTM) 36.47 -0.67 31.24
Effective Tax Rate - 5 Yr. Avg. 35.60 18.14 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,156,625 23,627,894 806,826,037
Net Income/Employee (TTM) 611,125 954,925 94,789,739
Receivable Turnover (TTM) 6.74 6.54 5.54
Inventory Turnover (TTM) 1.02 2.39 3.44
Asset Turnover (TTM) 0.66 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 18.79 -0.73 10.47
Return on Assets - 5 Yr. Avg. 22.07 0.66 11.49
Return on Investment (TTM) 22.08 -0.71 13.13
Return on Investment - 5 Yr. Avg. 28.00 4.08 14.88
Return on Equity (TTM) 24.55 -2.76 14.96
Return on Equity - 5 Yr. Avg. 31.01 -0.32 16.18
  1 Year 3 Year 5 Year
Sales % 7.91 10.22 13.50
EPS (TTM) % -28.60 20.14 13.76
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for United Therapeutics Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.22 2.30 72 9
13 Week -19.02 -15.87 27 74
26 Week -5.10 -9.72 48 88
52 Week -6.46 -18.79 50 78
YTD -23.63 -24.18 21 88
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 606
Total Shares Held: 44,623,107
3 Mo. Net Change: 166,515
# New Positions: 11
# Closed Positions: 8
# Increased Positions: 42
# Reduced Positions: 36
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.